伊人直播

Cookies on 伊人直播

We use some essential cookies to make this website work.

We鈥檇 like to set additional cookies to understand how you use 伊人直播, remember your settings and improve government services.

We also use cookies set by other sites to help us deliver content from their services.

You have accepted additional cookies. You can change your cookie settings at any time.

You have rejected additional cookies. You can change your cookie settings at any time.

View cookies

Benefits
Births, death, marriages and care
Business and self-employed
Childcare and parenting
Citizenship and living in the UK
Crime, justice and the law
Disabled people
Driving and transport
Education and learning
Employing people
Environment and countryside
Housing and local services
伊人直播 and tax
Passports, travel and living abroad
Visas and immigration
Working, jobs and pensions

Government activity

Departments
Departments, agencies and public bodies
News
News stories, speeches, letters and notices
Guidance and regulation
Detailed guidance, regulations and rules
Research and statistics
Reports, analysis and official statistics
Policy papers and consultations
Consultations and strategy
Transparency
Data, Freedom of Information releases and corporate reports

Search 伊人直播

Search

Search 伊人直播

Home
Health and social care
Medicines, medical devices
Vigilance, safety alerts and guidance
Alerts and recalls

Drug Safety Update

From:: Medicines and Healthcare products Regulatory Agency

Alerts, recalls and safety information: medicines and medical devices

Search Drug Safety Update

Skip to results

Filter

115 updates

Therapeutic area

Anaesthesia and intensive care

Breastfeeding

Cancer

Cardiovascular disease and lipidology

Care home staff

Cosmetic surgery

Critical care

Dentistry

Dermatology

Dispensing GP practices

Ear, nose and throat

Emergency medicine

Endocrinology, diabetology and metabolism

General practice

General surgery

GI, hepatology and pancreatic disorders

Haematology and oncology

Immunology and vaccination

Immunosuppression and transplantation

Infection prevention

Infectious disease

Neurology

Nutrition and dietetics

Obstetrics, gynaecology and fertility

Ophthalmology

Orthopaedics

Paediatrics and neonatology

Pain management and palliation

Pathology

Pharmacy

Physiotherapy and occupational therapy

Pregnancy

Psychiatry

Radiology and imaging

Renal medicine

Respiratory disease and allergy

Rheumatology

Theatre practitioners

Urology and nephrology

Vascular and cardiac surgery

Published

Published after

For example, 2005 or 21/11/2014

Published before

For example, 2005 or 21/11/2014

115 updates

About Anaesthesia and intensive care

Go to search results

115 updates

Skip to results

Subscribe to feed

115 updates

About Anaesthesia and intensive care

Hydroxyethyl starch intravenous infusion: suspension of licences

Clinical trials have reported an increased risk of renal dysfunction and mortality in critically ill or septic patients who received hydroxyethyl starch (HES) compared with crystalloids.
- Therapeutic area: Anaesthesia and intensive care
- Published: 11 December 2014
Dabigatran (Pradaxa): contraindicated in patients with prosthetic heart valve(s) requiring anti-coagulant treatment

Risk of thrombosis and haemorrhage in patients with prosthetic heart valve(s) requiring anti-coagulant treatment.
- Therapeutic area: Anaesthesia and intensive care and 1 others
- Published: 11 December 2014
Sprayable fibrin sealants (Evicel, Tisseel and Artiss): updated guidance

Updated guidance on minimising risk of life-threatening and fatal air embolism.
- Therapeutic area: Anaesthesia and intensive care
- Published: 11 December 2014
Codeine-containing pain relief in children

Safety review initiated following post-surgical fatalities in ultra-rapid metabolisers
- Therapeutic area: Anaesthesia and intensive care and 3 others
- Published: 11 December 2014
Intravenous 0.18% saline/4% glucose solution (鈥榟ypotonic saline鈥�) in children: reports of fatal hyponatraemia

Do not use in children aged 16 years or less, except in specialist settings under expert medical supervision.
- Therapeutic area: Anaesthesia and intensive care and 2 others
- Published: 11 December 2014
Treating paracetamol overdose with intravenous acetylcysteine: new guidance

New simplified guidance on treating paracetamol overdose with intravenous acetylcysteine including an updated treatment nomogram.
- Therapeutic area: Anaesthesia and intensive care and 2 others
- Published: 11 December 2014
Ondansetron (Zofran): important new intravenous dose restriction

New maximum single intravenous dose of ondansetron for the management of chemotherapy-induced nausea and vomiting (CINV) restricted due to risk of QTc prolongation.
- Therapeutic area: Anaesthesia and intensive care and 1 others
- Published: 11 December 2014
Glucose solutions: false blood glucose readings when used to flush arterial lines

False blood glucose readings when used to flush arterial lines leading to incorrect insulin administration and potentially fatal hypoglycaemia.
- Therapeutic area: Anaesthesia and intensive care
- Published: 11 December 2014
Report adverse reactions associated with intra-articular use of local anaesthetics

The Food and Drug Administration (FDA) has received 35 reports of chondrolysis involving patients given continuous intra-articular infusions of local anaesthetics.
- Therapeutic area: Anaesthesia and intensive care
- Published: 11 December 2014
High-dose cyproterone acetate: potential risk of (multiple) meningiomas

Patients with existing meningioma or a history of meningioma must not be prescribed high-dose (鈮�25 mg per day) cyproterone acetate.
- Therapeutic area: Anaesthesia and intensive care and 3 others
- Published: 11 December 2014
The Black Triangle Scheme (鈻� or 鈻�*)

Continued monitoring of medicines with a black triangle status.
- Therapeutic area: Anaesthesia and intensive care and 6 others
- Published: 11 December 2014
Nitrous oxide: neurological and haematological toxic effects

Toxic effects can occur with nitrous oxide especially with prolonged use.
- Therapeutic area: Anaesthesia and intensive care and 1 others
- Published: 11 December 2014
Injectable medicines for cosmetic procedures: supply and administration

Updated guidance on the supply and administration of Botox, Vistabel, Dysport, and other injectable medicines used in cosmetic procedures.
- Therapeutic area: Anaesthesia and intensive care
- Published: 11 December 2014
Ecoflac infusion solutions: risk of air embolism

To avoid the risk of air embolism, these products should not be infused under pressure.
- Therapeutic area: Anaesthesia and intensive care and 22 others
- Published: 11 December 2014
Corticosteroids: early psychiatric side-effects

Risk of early psychiatric side-effects is one of several important safety issues for healthcare professionals to discuss with patients and carers, who should seek urgent medical advice in the event of any worrying symptoms.
- Therapeutic area: Anaesthesia and intensive care and 9 others
- Published: 11 December 2014

Previous page : 2 of 3

Subscribe to feed

Is this page useful?

Thank you for your feedback

Help us improve 伊人直播

Don鈥檛 include personal or financial information like your National Insurance number or credit card details.

This field is for robots only. Please leave blank

What were you doing?

What went wrong?

Help us improve 伊人直播

To help us improve 伊人直播, we鈥檇 like to know more about your visit today. .

Services and information

Benefits
Births, death, marriages and care
Business and self-employed
Childcare and parenting
Citizenship and living in the UK
Crime, justice and the law
Disabled people
Driving and transport
Education and learning
Employing people
Environment and countryside
Housing and local services
伊人直播 and tax
Passports, travel and living abroad
Visas and immigration
Working, jobs and pensions

Government activity

Departments
News
Guidance and regulation
Research and statistics
Policy papers and consultations
Transparency
How government works
Get involved

All content is available under the , 伊人直播